𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Synergistic anti-proliferative and pro-apoptotic activity of combined therapy with bortezomib, a proteasome inhibitor, with anti-epidermal growth factor receptor (EGFR) drugs in human cancer cells

✍ Scribed by Tina Cascone; Maria Pia Morelli; Floriana Morgillo; Woo-Young Kim; Gabriella Rodolico; Stefano Pepe; Giampaolo Tortora; Liberato Berrino; Ho-Young Lee; John V. Heymach; Fortunato Ciardiello

Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
29 KB
Volume
217
Category
Article
ISSN
0021-9541

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The article to which this erratum refers was published in J Cell Physiol (2008) 216: 698–707. Β© 2008 Wiley‐Liss, Inc. DOI: 10.1002/jcp.21444

πŸ“œ SIMILAR VOLUMES

Synergistic anti-proliferative and pro-a
Synergistic anti-proliferative and pro-apoptotic activity of combined therapy with bortezomib, a proteasome inhibitor, with anti-epidermal growth factor receptor (EGFR) drugs in human cancer cells
✍ Tina Cascone; Maria Pia Morelli; Floriana Morgillo; Woo-Young Kim; Gabriella Rod πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 356 KB πŸ‘ 1 views

## Abstract The proteasome plays a pivotal role in the turnover of regulatory transduction proteins induced by activated cell membrane growth factor receptors. The epidermal growth factor receptor (EGFR) pathway is crucial in the development and progression of human epithelial cancers. Proteasome i